JSPR — Jasper Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. RESEARCH ROUNDUP-Antero Resources, IGM Biosciences, Lennar
U.S. STOCKS ON THE MOVE-Chart Industries, Accolade, Carvana
Jasper Therapeutics falls about 50% after early-stage data for skin disease drug
Brief: Jasper Therapeutics Reports Positive Data From Beacon Study Of Briquilimab In Chronic Spontaneous Urticaria
Brief: Jasper Therapeutics Announces First Patient Dosed In Phase 1B/2A Etesian Clinical Study
Jasper Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
Jasper Therapeutics Inc expected to post a loss of $1.07 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Bausch + Lomb, SpartanNash, Hologic
U.S. STOCKS ON THE MOVE-Adobe, BigBear.ai, PG&E
Jasper Therapeutics rises on prelim early-stage data for skin disease drug
Brief: Jasper Therapeutics Reports Positive Data From Spotlight Study Of Briquilimab
Brief: Jasper Therapeutics Says Dosing To Commence In Q4 2024, Initial Data In H2 2025
Jasper Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Jasper Therapeutics Inc expected to post a loss of $1.09 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Gold miners, Nikola, Cruise stocks
U.S. STOCKS ON THE MOVE-Ally Financial, Ideaya Biosciences, Brinker
Jasper Therapeutics rises as BTIG initiates with 'buy' rating
Jasper Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Jasper Therapeutics Announces Briquilimab Development Program In Asthma